Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Trauner

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liverT A Koeppel, M Trauner, J C Baas, et al.
ESMO Open|February 8, 2023
Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohortK Pomej, L Balcar, K Shmanko, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severityM Mandorfer, P Schwabl, R Paternostro, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertensionM Mandorfer, B Scheiner, A F Stättermayer, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver diseaseP Schwabl, M Mandorfer, S Steiner, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Alimentary Pharmacology & Therapeutics|August 24, 2016
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological referenceM Munteanu, D Tiniakos, Q Anstee, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2018
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleedingN Pfisterer, C Dexheimer, E-M Fuchs, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Alimentary Pharmacology & Therapeutics|October 4, 2014
Gender- and site-specific differences of colorectal neoplasia relate to vitamin DE Aigner, A Stadlmayr, U Huber-Schönauer, et al.
Hepatology (Baltimore, Md.)|November 15, 1997
Extrahepatic biliary obstruction impairs microvascular perfusion and increases leukocyte adhesion in rat liverT A Koeppel, M Trauner, J C Baas, et al.
ESMO Open|February 8, 2023
Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma-a European multicenter cohortK Pomej, L Balcar, K Shmanko, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severityM Mandorfer, P Schwabl, R Paternostro, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertensionM Mandorfer, B Scheiner, A F Stättermayer, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver diseaseP Schwabl, M Mandorfer, S Steiner, et al.
Alimentary Pharmacology & Therapeutics|November 12, 2013
Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis CA F Stättermayer, R Strassl, A Maieron, et al.
Alimentary Pharmacology & Therapeutics|August 24, 2016
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological referenceM Munteanu, D Tiniakos, Q Anstee, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2018
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleedingN Pfisterer, C Dexheimer, E-M Fuchs, et al.
Pageof 10